Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Carbohydr Res ; 542: 109205, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38981321

ABSTRACT

There has been a sudden increase in viral diseases, such as coronavirus disease 2019 (COVID-19), causing significant harm to human and animal well-being, as well as economic development. Medicinal herbs, with a history of thousands of years in clinical use, contain versatile polysaccharides as one of their primary compounds. This review offers an overview of the antiviral effects of polysaccharides from medicinal herbs on viruses in humans, poultry, swine and aquaculture in recent years. The mechanism of these antiviral polysaccharides, involved in hindering various stages of the viral life cycle thereby blocking virus infection, is summarized. The review also explores other underlying mechanisms of antiviral effects, such as enhancing the immune response, regulating inflammatory reactions, balancing gut flora, reducing oxidative stress, and suppressing apoptosis through various corresponding signaling pathways. The structure-function relationships discussed in this article also aid in understanding the antiviral mechanism of natural polysaccharides, indicating the need for more in-depth research and analysis. Natural polysaccharides from medicinal herbs have emerged as valuable resources in the fight against viral infections, exhibiting high effectiveness. This review emphasizes the promising role of polysaccharides from medicinal herbs as potential candidates for blocking viral infections in humans and animals.


Subject(s)
Antiviral Agents , Plants, Medicinal , Polysaccharides , Antiviral Agents/pharmacology , Antiviral Agents/chemistry , Polysaccharides/chemistry , Polysaccharides/pharmacology , Humans , Plants, Medicinal/chemistry , Animals , SARS-CoV-2/drug effects , COVID-19 Drug Treatment
2.
Emerg Microbes Infect ; 12(1): 2164742, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36591809

ABSTRACT

Viral envelope glycoproteins are crucial for viral infections. In the process of enveloped viruses budding and release from the producer cells, viral envelope glycoproteins are presented on the viral membrane surface as spikes, promoting the virus's next-round infection of target cells. However, the host cells evolve counteracting mechanisms in the long-term virus-host co-evolutionary processes. For instance, the host cell antiviral factors could potently suppress viral replication by targeting their envelope glycoproteins through multiple channels, including their intracellular synthesis, glycosylation modification, assembly into virions, and binding to target cell receptors. Recently, a group of studies discovered that some host antiviral proteins specifically recognized host proprotein convertase (PC) furin and blocked its cleavage of viral envelope glycoproteins, thus impairing viral infectivity. Here, in this review, we briefly summarize several such host antiviral factors and analyze their roles in reducing furin cleavage of viral envelope glycoproteins, aiming at providing insights for future antiviral studies.


Subject(s)
COVID-19 , Ebolavirus , HIV-1 , Hemorrhagic Fever, Ebola , Virus Diseases , Humans , Furin/metabolism , Viral Envelope Proteins/metabolism , SARS-CoV-2/metabolism , Antiviral Agents/pharmacology , Glycoproteins
SELECTION OF CITATIONS
SEARCH DETAIL